Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

User Fees To Rise 16% As FDA Backs Historical Data Over Industry Estimates

This article was originally published in The Gray Sheet

Executive Summary

FDA is declining to adopt an industry proposal that would have halved the agency's projected 18% PMA user fee hike for fiscal 2005

You may also be interested in...



Senate Appropriations Committee Clears President’s Full MDUFMA Request

The Medical Device Manufacturers Association is appealing to AdvaMed to ponder substantive changes to MDUFMA at the larger group's board meeting in Washington, D.C. Sept. 22-23

Senate Appropriations Committee Clears President’s Full MDUFMA Request

The Medical Device Manufacturers Association is appealing to AdvaMed to ponder substantive changes to MDUFMA at the larger group's board meeting in Washington, D.C. Sept. 22-23

Oct. 20 Meeting Tentatively Scheduled For User Fees, Performance Goals

FDA expects to meet with device industry reps Oct. 20 to review ongoing concerns with the user fee program, including whether the baseline data used to set MDUFMA performance goals were appropriate

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020601

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel